Advertisement
Home Blog Page 1346

Isolated Small Fiber Neuropathy Increasing in Incidence

0

Patients with small fiber neuropathy did not self-identify as disabled, but many have multiple comorbidities

ACS: Surgery May Follow Initial Antibiotic Therapy for Appendicitis

0

At one and two years, 40 and 46 percent of patients initially receiving antibiotics underwent subsequent appendectomy

Itepekimab Bests Placebo for Moderate-to-Severe Asthma

0

Incidence of events indicating loss of asthma control lower with itepekimab monotherapy in phase 2, proof-of-concept trial

Parkinson Disease Mortality Up in U.S. From 1999 to 2019

0

Increases seen across all age groups, both sexes, various racial/ethnic groups, different urban/rural classifications

Sotrovimab Cuts Risk for COVID-19 Progression in High-Risk Patients

0

Interim analysis shows lower risk for progression with sotrovimab versus placebo among high-risk patients with mild-to-moderate COVID-19

Fluvoxamine Cuts Hospitalizations in High-Risk COVID-19 Outpatients

0

Rate of high-risk COVID-19 outpatients needing prolonged emergency care or transfer to tertiary hospital lower with fluvoxamine versus placebo

Impact of Dietary Interventions Inconsistent in Rheumatoid Arthritis

0

Dietary interventions combined with omega-3 supplementation may provide additional benefit

Immunocompromised May Need Fourth COVID-19 Shot: CDC

0

Small studies have shown that fully vaccinated immunocompromised people account for ~44 percent of breakthrough cases leading to hospitalization

Merck Allows Poor Nations to Make COVID-19 Pill

0

Royalty-free license means companies in 105 countries can sublicense the formulation for antiviral pill molnupiravir and start making it